Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Study explores how CAR T immunotherapy could be used to treat solid tumors

Study explores how CAR T immunotherapy could be used to treat solid tumors

Anti-inflammatory therapies may help prevent heart disease in people with age-related blood condition

Anti-inflammatory therapies may help prevent heart disease in people with age-related blood condition

ALSF announces grant award recipients of Crazy 8 Initiative in pediatric oncology

ALSF announces grant award recipients of Crazy 8 Initiative in pediatric oncology

Researchers identify epigenetic mechanism responsible for lifelong stress susceptibility

Researchers identify epigenetic mechanism responsible for lifelong stress susceptibility

Discovery may help cancer patients to avoid chemotherapy's debilitating side effects

Discovery may help cancer patients to avoid chemotherapy's debilitating side effects

Novel computer-guided design tool helps increase the efficiency of cell conversions

Novel computer-guided design tool helps increase the efficiency of cell conversions

Cancer cells may dodge chemotherapy by going into 'active hibernation'

Cancer cells may dodge chemotherapy by going into 'active hibernation'

New book explains concept and knowledge maps about biochemical compounds

New book explains concept and knowledge maps about biochemical compounds

Studies reveal how kidney tumors' microenvironments change in response to immunotherapy

Studies reveal how kidney tumors' microenvironments change in response to immunotherapy

Whole genome sequencing may guide blood cancer treatment

Whole genome sequencing may guide blood cancer treatment

Researchers establish organoid culture models from prostate tumor biopsies

Researchers establish organoid culture models from prostate tumor biopsies

CAR T-cell therapy triples expected length of remission for relapsed multiple myeloma patients

CAR T-cell therapy triples expected length of remission for relapsed multiple myeloma patients

New inhibitor makes drug-resistant tumor cells respond again to chemotherapy

New inhibitor makes drug-resistant tumor cells respond again to chemotherapy

Weedy grass may be effective against several human diseases

Weedy grass may be effective against several human diseases

Experimental safety switch reduces severity of CAR-T immunotherapy-related side effects

Experimental safety switch reduces severity of CAR-T immunotherapy-related side effects

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

Study reports persistent SARS-CoV-2 with increasing viral variants in pediatric patients

Study reports persistent SARS-CoV-2 with increasing viral variants in pediatric patients

Scientists report new insights into the development of blood cancers

Scientists report new insights into the development of blood cancers

Children with MIS-C have highly activated immune systems, study finds

Children with MIS-C have highly activated immune systems, study finds

Emerging protein-based immunotherapies could lead to highly effective cancer treatments

Emerging protein-based immunotherapies could lead to highly effective cancer treatments

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.